CLINICAL_TRIALS
research
· 2025-02-05
Clinical Trial Update: Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W [Phase 2]
Summary
Phase 2 trial evaluating a four-modality bladder-preservation strategy (TURBT with chemo/immunotherapy, radiation, and maintenance immunotherapy) versus watchfu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: American University of Beirut Medical Center | Conditions: Muscle-invasive Bladder Cancer | Phase 2 | Status: NOT_YET_RECRUITING